Thomas Madden
Amministratore Delegato presso Acuitas Therapeutics, Inc.
Posizioni attive di Thomas Madden
Società | Posizione | Inizio | Fine |
---|---|---|---|
Acuitas Therapeutics, Inc.
Acuitas Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Acuitas Therapeutics is a private biotechnology company based in Vancouver, Canada that specializes in developing delivery systems for nucleic acid therapeutics based on lipid nanoparticles. The Canadian company partners with pharmaceutical and biotechnology companies, academic institutes, and non-governmental organizations to advance nucleic acid therapeutics into clinical trials and the marketplace. Acuitas Therapeutics has agreements in place with several partners to use its proprietary lipid nanotechnology in the development of COVID-19 vaccines, including Pfizer/BioNTech for Comirnaty®. The CEO of the company is Thomas Madden. | Amministratore Delegato | - | - |
Presidente | - | - |
Storia della carriera di Thomas Madden
Statistiche
Distribuzione geografica
Canada | 2 |
Posizioni
Chief Executive Officer | 1 |
President | 1 |
Settori
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Acuitas Therapeutics, Inc.
Acuitas Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Acuitas Therapeutics is a private biotechnology company based in Vancouver, Canada that specializes in developing delivery systems for nucleic acid therapeutics based on lipid nanoparticles. The Canadian company partners with pharmaceutical and biotechnology companies, academic institutes, and non-governmental organizations to advance nucleic acid therapeutics into clinical trials and the marketplace. Acuitas Therapeutics has agreements in place with several partners to use its proprietary lipid nanotechnology in the development of COVID-19 vaccines, including Pfizer/BioNTech for Comirnaty®. The CEO of the company is Thomas Madden. | Commercial Services |
- Borsa valori
- Insiders
- Thomas Madden
- Esperienza